ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Novel Vaccine Delivery Systems Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33I9876
Home | Market Reports | Health| Nursing
Global Novel Vaccine Delivery Systems Market Research Report 2022
BUY CHAPTERS

Global Novel Vaccine Delivery Systems Market Research Report 2025

Code: QYRE-Auto-33I9876
Report
March 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Becton
Dickinson
Carl Zeiss Foundation
Gerresheimer
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
Vaxxas
Altaris Capital Partners
Kindeva Drug Delivery

Novel Vaccine Delivery Systems Market Size

The global market for Novel Vaccine Delivery Systems was valued at US$ 7163 million in the year 2024 and is projected to reach a revised size of US$ 14540 million by 2031, growing at a CAGR of 10.8% during the forecast period.

Novel Vaccine Delivery Systems Market

Novel Vaccine Delivery Systems Market

Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Novel Vaccine Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Vaccine Delivery Systems.
The Novel Vaccine Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Novel Vaccine Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Vaccine Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Novel Vaccine Delivery Systems Market Report

Report Metric Details
Report Name Novel Vaccine Delivery Systems Market
Accounted market size in year US$ 7163 million
Forecasted market size in 2031 US$ 14540 million
CAGR 10.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals & Clinics
  • Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals, Bioject Medical Technologies, PharmaJet, Retractable Technologies, Terumo Corporation, VAXXAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Novel Vaccine Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Novel Vaccine Delivery Systems Market growing?

Ans: The Novel Vaccine Delivery Systems Market witnessing a CAGR of 10.8% during the forecast period 2025-2031.

What is the Novel Vaccine Delivery Systems Market size in 2031?

Ans: The Novel Vaccine Delivery Systems Market size in 2031 will be US$ 14540 million.

Who are the main players in the Novel Vaccine Delivery Systems Market report?

Ans: The main players in the Novel Vaccine Delivery Systems Market are Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals, Bioject Medical Technologies, PharmaJet, Retractable Technologies, Terumo Corporation, VAXXAS

What are the Application segmentation covered in the Novel Vaccine Delivery Systems Market report?

Ans: The Applications covered in the Novel Vaccine Delivery Systems Market report are Hospitals & Clinics, Research Institutes, Others

What are the Type segmentation covered in the Novel Vaccine Delivery Systems Market report?

Ans: The Types covered in the Novel Vaccine Delivery Systems Market report are Intradermal Delivery, Intramuscular Delivery, Others

Recommended Reports

Vaccine Markets

Drug Delivery Systems

Modern Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intradermal Delivery
1.2.3 Intramuscular Delivery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Novel Vaccine Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Vaccine Delivery Systems Market Perspective (2020-2031)
2.2 Global Novel Vaccine Delivery Systems Growth Trends by Region
2.2.1 Global Novel Vaccine Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2020-2025)
2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2026-2031)
2.3 Novel Vaccine Delivery Systems Market Dynamics
2.3.1 Novel Vaccine Delivery Systems Industry Trends
2.3.2 Novel Vaccine Delivery Systems Market Drivers
2.3.3 Novel Vaccine Delivery Systems Market Challenges
2.3.4 Novel Vaccine Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue
3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2020-2025)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2020-2025)
3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Novel Vaccine Delivery Systems Revenue
3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2024
3.5 Global Key Players of Novel Vaccine Delivery Systems Head office and Area Served
3.6 Global Key Players of Novel Vaccine Delivery Systems, Product and Application
3.7 Global Key Players of Novel Vaccine Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Vaccine Delivery Systems Breakdown Data by Type
4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2020-2025)
4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2026-2031)
5 Novel Vaccine Delivery Systems Breakdown Data by Application
5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2020-2025)
5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Novel Vaccine Delivery Systems Market Size (2020-2031)
6.2 North America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2020-2025)
6.4 North America Novel Vaccine Delivery Systems Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Vaccine Delivery Systems Market Size (2020-2031)
7.2 Europe Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2020-2025)
7.4 Europe Novel Vaccine Delivery Systems Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2020-2031)
8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2020-2025)
8.4 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Vaccine Delivery Systems Market Size (2020-2031)
9.2 Latin America Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2020-2025)
9.4 Latin America Novel Vaccine Delivery Systems Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2020-2031)
10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2020-2025)
10.4 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Details
11.1.2 Altaris Capital Partners Business Overview
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction
11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.1.5 Altaris Capital Partners Recent Development
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Details
11.2.2 Kindeva Drug Delivery Business Overview
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction
11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.2.5 Kindeva Drug Delivery Recent Development
11.3 Becton
11.3.1 Becton Company Details
11.3.2 Becton Business Overview
11.3.3 Becton Novel Vaccine Delivery Systems Introduction
11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.3.5 Becton Recent Development
11.4 Dickinson,
11.4.1 Dickinson, Company Details
11.4.2 Dickinson, Business Overview
11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction
11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.4.5 Dickinson, Recent Development
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Details
11.5.2 Carl Zeiss Foundation Business Overview
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction
11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.5.5 Carl Zeiss Foundation Recent Development
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Details
11.6.2 Gerresheimer AG Business Overview
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction
11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.6.5 Gerresheimer AG Recent Development
11.7 Corium International
11.7.1 Corium International Company Details
11.7.2 Corium International Business Overview
11.7.3 Corium International Novel Vaccine Delivery Systems Introduction
11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.7.5 Corium International Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Details
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Details
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction
11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.9.5 Bioject Medical Technologies Recent Development
11.10 PharmaJet
11.10.1 PharmaJet Company Details
11.10.2 PharmaJet Business Overview
11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction
11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.10.5 PharmaJet Recent Development
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Details
11.11.2 Retractable Technologies Business Overview
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction
11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.11.5 Retractable Technologies Recent Development
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Details
11.12.2 Terumo Corporation Business Overview
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction
11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.12.5 Terumo Corporation Recent Development
11.13 VAXXAS
11.13.1 VAXXAS Company Details
11.13.2 VAXXAS Business Overview
11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction
11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2020-2025)
11.13.5 VAXXAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Becton
Dickinson
Carl Zeiss Foundation
Gerresheimer
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
Vaxxas
Altaris Capital Partners
Kindeva Drug Delivery
List of Tables
 Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Intradermal Delivery
 Table 3. Key Players of Intramuscular Delivery
 Table 4. Key Players of Others
 Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2020-2025)
 Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2026-2031)
 Table 11. Novel Vaccine Delivery Systems Market Trends
 Table 12. Novel Vaccine Delivery Systems Market Drivers
 Table 13. Novel Vaccine Delivery Systems Market Challenges
 Table 14. Novel Vaccine Delivery Systems Market Restraints
 Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2020-2025)
 Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2024)
 Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Novel Vaccine Delivery Systems, Headquarters and Area Served
 Table 21. Global Key Players of Novel Vaccine Delivery Systems, Product and Application
 Table 22. Global Key Players of Novel Vaccine Delivery Systems, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2020-2025)
 Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2026-2031)
 Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2020-2025)
 Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2026-2031)
 Table 32. North America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Novel Vaccine Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Altaris Capital Partners Company Details
 Table 48. Altaris Capital Partners Business Overview
 Table 49. Altaris Capital Partners Novel Vaccine Delivery Systems Product
 Table 50. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 51. Altaris Capital Partners Recent Development
 Table 52. Kindeva Drug Delivery Company Details
 Table 53. Kindeva Drug Delivery Business Overview
 Table 54. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product
 Table 55. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 56. Kindeva Drug Delivery Recent Development
 Table 57. Becton Company Details
 Table 58. Becton Business Overview
 Table 59. Becton Novel Vaccine Delivery Systems Product
 Table 60. Becton Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 61. Becton Recent Development
 Table 62. Dickinson, Company Details
 Table 63. Dickinson, Business Overview
 Table 64. Dickinson, Novel Vaccine Delivery Systems Product
 Table 65. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 66. Dickinson, Recent Development
 Table 67. Carl Zeiss Foundation Company Details
 Table 68. Carl Zeiss Foundation Business Overview
 Table 69. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product
 Table 70. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 71. Carl Zeiss Foundation Recent Development
 Table 72. Gerresheimer AG Company Details
 Table 73. Gerresheimer AG Business Overview
 Table 74. Gerresheimer AG Novel Vaccine Delivery Systems Product
 Table 75. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 76. Gerresheimer AG Recent Development
 Table 77. Corium International Company Details
 Table 78. Corium International Business Overview
 Table 79. Corium International Novel Vaccine Delivery Systems Product
 Table 80. Corium International Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 81. Corium International Recent Development
 Table 82. Inovio Pharmaceuticals Company Details
 Table 83. Inovio Pharmaceuticals Business Overview
 Table 84. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product
 Table 85. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 86. Inovio Pharmaceuticals Recent Development
 Table 87. Bioject Medical Technologies Company Details
 Table 88. Bioject Medical Technologies Business Overview
 Table 89. Bioject Medical Technologies Novel Vaccine Delivery Systems Product
 Table 90. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 91. Bioject Medical Technologies Recent Development
 Table 92. PharmaJet Company Details
 Table 93. PharmaJet Business Overview
 Table 94. PharmaJet Novel Vaccine Delivery Systems Product
 Table 95. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 96. PharmaJet Recent Development
 Table 97. Retractable Technologies Company Details
 Table 98. Retractable Technologies Business Overview
 Table 99. Retractable Technologies Novel Vaccine Delivery Systems Product
 Table 100. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 101. Retractable Technologies Recent Development
 Table 102. Terumo Corporation Company Details
 Table 103. Terumo Corporation Business Overview
 Table 104. Terumo Corporation Novel Vaccine Delivery Systems Product
 Table 105. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 106. Terumo Corporation Recent Development
 Table 107. VAXXAS Company Details
 Table 108. VAXXAS Business Overview
 Table 109. VAXXAS Novel Vaccine Delivery Systems Product
 Table 110. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2020-2025) & (US$ Million)
 Table 111. VAXXAS Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Novel Vaccine Delivery Systems Picture
 Figure 2. Global Novel Vaccine Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Novel Vaccine Delivery Systems Market Share by Type: 2024 VS 2031
 Figure 4. Intradermal Delivery Features
 Figure 5. Intramuscular Delivery Features
 Figure 6. Others Features
 Figure 7. Global Novel Vaccine Delivery Systems Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Novel Vaccine Delivery Systems Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals & Clinics Case Studies
 Figure 10. Research Institutes Case Studies
 Figure 11. Others Case Studies
 Figure 12. Novel Vaccine Delivery Systems Report Years Considered
 Figure 13. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Novel Vaccine Delivery Systems Market Share by Region: 2024 VS 2031
 Figure 16. Global Novel Vaccine Delivery Systems Market Share by Players in 2024
 Figure 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2024
 Figure 19. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Novel Vaccine Delivery Systems Market Share by Country (2020-2031)
 Figure 21. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Novel Vaccine Delivery Systems Market Share by Country (2020-2031)
 Figure 25. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2020-2031)
 Figure 33. China Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Novel Vaccine Delivery Systems Market Share by Country (2020-2031)
 Figure 41. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2020-2031)
 Figure 45. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Novel Vaccine Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 49. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 50. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 51. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 52. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 53. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 54. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 55. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 56. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 57. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 58. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 59. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 60. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Pharmaceutics and Novel Drug Delivery Systems Market Insights Forecast to 2030
Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030
Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030
Global Oral Delivery Vaccines Market Research Report 2025
Global Noninvasive Delivery Vaccine Market Research Report 2025
Dental Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Drug Delivery System Market Research Report 2025
Next Generation Diabetes Therapy and Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intranasal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine for Human Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intranasal Drug and Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Technologies for Delivery of Proteins Antibodies and Nucleic Acids Market Insights Forecast to 2030
Global Drug Delivery Technology Market Research Report 2024
Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Delivery Systems in Personal Care Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Novel Drug Delivery Systems Market Research Report 2025

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions